In this article, We will analyze BAFNA PHARMA to build a profitable portfolio, and also pivot technical analysis..
52 WEEK HIGH AND 52 WEEK LOW
BAFNA PHARMA 52 week high is 195.95 and 52 week low is 13.05 .
EPS
BAFNA PHARMA earning per share is 0.88
VWAP
VWAP level is 131.26 based on the closing price. This is on hourly chart
Revenue
The BAFNA PHARMA Net Revenue from last quarter is 21.26 crore.
FACE VALUE
The BAFNA PHARMA Face value is 10.00.
Market Capital
The BAFNA PHARMA Full Market Capital is 306.47 crore.
INDUSTRY
BAFNA PHARMA is listed under industry.
Index
BAFNA PHARMA is part of the B Index Group.
